MEAK7 and non-small cell lung carcinoma: Thus, mEAK-7 protein and activated mTOR signaling was found to be enhanced in primary NSCLC, and substantially detected in metastasized lymph nodes, suggesting that mEAK-7 could function as a biomarker for patients with metastasized cancers.